GlassScriptPhysician profile
James W Blackstone
NPI 1477523090
$1,141.43
in general payments reported to CMS, 2019-2025
14 companies · $85.43 in 2025
The $85.43 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2020: $161 · 2021: $180 · 2022: $53.19 · 2023: $91.11 · 2024: $427 · 2025: $85.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $324 · Long Term Medical Supply Or Device Loan: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $323.54 |
| Long Term Medical Supply Or Device Loan | $280.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ocular Therapeutix, INC. | $349.89 | 2024-2025 | Dextenza |
| Alcon Vision LLC | $163.13 | 2019-2025 | Clareon |
| Johnson & Johnson Surgical Vision, INC. | $142.08 | 2019-2024 | Tecnis Simplicity, Tecnis Iol, Amo Phaco Needle |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $129.92 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $79.37 | 2019-2021 | |
| Allergan, INC. | $71.15 | 2020-2021 | |
| Bausch & Lomb Americas INC. | $45.81 | 2022-2023 | Vyzulta |
| Sight Sciences, INC. | $32.44 | 2024 | Omni Surgical System |
| Abbvie INC. | $31.30 | 2023 | Durysta |
| Ivantis, INC | $27.18 | 2021 | |
| Dompe US, INC. | $25.86 | 2025 | Oxervate |
| Sun Pharmaceutical Industries INC. | $18.59 | 2019 | |
| Oyster Point Pharma, INC. | $15.54 | 2022 | |
| Iridex Corporation | $9.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Blackstone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.